Cochlear Benelux NV

What Cochlear Benelux NV does

Cochlear Benelux NV is the Benelux regional subsidiary of Cochlear Ltd (ASX:COH), a publicly listed Australian parent and global leader in implantable hearing solutions. Operating from Mechelen in the Flemish Region of Belgium with a lean six-person team, the entity coordinates the marketing, clinical-channel support, and patient services for the Benelux region, covering Belgium, the Netherlands, and Luxembourg. Its commercial footprint is governed by the parent's broader portfolio rather than autonomous product development.

The company's offering consists of cochlear implant systems and bone conduction hearing solutions. Core products include the Nucleus Nexa System (marketed as the first and only "smart" cochlear implant system), the Nucleus Kanso 3 off-the-ear sound processor, the Baha 7 bone conduction sound processor, and the Osia bone conduction implant system. These address severe-to-profound sensorineural hearing loss, conductive and mixed hearing loss, and single-sided deafness, spanning both adult and pediatric indications. The technology stack rests on proprietary implant hardware, miniaturized sound processors, and brand-specific fitting/mapping software tied to a recurring accessories and consumables line.

Cochlear Benelux generates revenue predominantly through hardware sales of medical devices, executed via an enterprise, healthcare-professional-guided go-to-market motion. Distribution flows through the Cochlear Expertise- en Adviescentra network, specialized audiologists, ENT clinics and surgical hospitals, with patients typically referred by ENT specialists and audiologists. Pricing is quote-based and not publicly disclosed. A complementary direct-to-consumer online shop sells accessories and replacement parts, while ongoing device support, information sessions, and patient-story content serve the longer funnel of patient education and conversion.

Name

Cochlear Benelux NV

Legal name

Cochlear Benelux NV

Website

https://cochlear.nl

Company type

Public

Operating status

Operating

Headcount range

1–10 employees

Short description

Cochlear Benelux NV is a regional subsidiary of Cochlear Ltd (ASX:COH) that markets and supports implantable hearing solutions — cochlear implants and bone conduction systems — across Belgium, the Netherlands, and Luxembourg via a clinical channel of specialized audiologists, expertise centers, and ENT clinics.

Ownership category

akta.pro rank

Product category

Cochlear Implants and Hearing Implant Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Audiology & Hearing Services (ENT-Affiliated) (HLAKAMAI)

akta.pro secondary industry

Otology & Neurotology (Ear/Hearing/Balance) (HLAKAMAC)

Keywords

• Cochlear implant systems
• Bone conduction implants
• Implantable hearing solutions
• Hearing loss treatment
• Hearing implant devices

Headquarters

HQ city

Benelux region

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

Revenue model

1. Cochlear Implant Systems: Sale of cochlear implant devices including the Nucleus implant and external sound processor components. These are medical devices typically sold through clinical channels with surgical implantation procedures.
2. Bone Conduction Systems: Sale of Baha and Osia bone conduction implant systems for patients with conductive or mixed hearing loss, or single-sided deafness.
3. Accessories and Consumables: Sale of accessories, replacement parts, and consumables for sound processors. Shop available on website for accessories.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Cochlear Benelux NV sells and distributes implantable hearing solutions across Belgium, the Netherlands, and Luxembourg. Its portfolio includes cochlear implant systems (Nucleus Nexa and Nucleus Kanso 3) for severe-to-profound sensorineural hearing loss, and bone conduction systems (Baha and Osia) for conductive hearing loss, mixed hearing loss, and single-sided deafness. The company also sells replacement accessories and consumables for its sound processors through an online shop.

Product overview

Cochlear Benelux NV offers a portfolio of implantable hearing solutions. The core offerings include the Nucleus Nexa System (the world's first smart cochlear implant), the Nucleus Kanso 3 off-the-ear sound processor, the Baha 7 bone conduction sound processor, and the Osia System. These products work together to address different types of hearing loss: cochlear implants for severe-to-profound hearing loss, and bone conduction systems (Baha and Osia) for conductive hearing loss, mixed hearing loss, or single-sided deafness.

Differentiator

Problem solved

Functional benefit

Brands

• Nucleus: Cochlear implant system brand featuring sound processors including Nucleus Nexa and Nucleus Kanso 3
• Baha
• Osia

Products and services

• Nucleus Nexa System

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Specialized Audiologists in the Netherlands and BelgiumcoreChannel Partner/ Reseller/ DistributorCochlear works with specialized audiologists throughout the Benelux region. These professionals provide consultations, product demonstrations, and ongoing support for Cochlear hearing implant users. The audiologists are an essential part of the patient journey from initial consultation through device fitting and ongoing care.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• MED-EL: MED-EL is one of the world's three major cochlear implant manufacturers and the most direct competitor to Cochlear. It offers competing cochlear implant systems and audiology-processor products sold through clinical channels in Europe, including the Benelux region.
• Advanced Bionics: Advanced Bionics, owned by Sonova, is the third global cochlear implant manufacturer and a direct competitor to Cochlear's Nucleus line. It sells cochlear implants and sound processors through clinical and audiology channels overlapping with Cochlear's go-to-market.

Broad incumbents

• Demant: Demant is a major hearing healthcare group (Oticon, Bernafon, Sonic, Philips Hearing Solutions). It is a broad incumbent in the same audiology and hearing-care space Cochlear operates in, competing for clinical-channel mindshare and patient referrals in Benelux.
• GN Hearing: GN Hearing (ReSound, Jabra, Beltone) is one of the world's largest hearing aid manufacturers. It competes with Cochlear indirectly by serving milder hearing loss patients and competing for audiologist relationships and clinic partnerships in the Benelux region.
• Starkey Hearing Technologies: Starkey is a major U.S.-based hearing aid manufacturer with growing European presence. It competes for audiology-channel share and patient referrals with Cochlear in the Benelux hearing-care market.
• Sonova: Sonova is a global hearing healthcare leader (Phonak, Unitron) and parent of Advanced Bionics. It overlaps with Cochlear through cochlear implants (via AB) and competes broadly across hearing aids, accessories, and audiology services in the Benelux market.
• WS Audiology: WS Audiology (Widex, Signia, Sivantos) is a leading hearing aid manufacturer serving the same audiology and clinical channels as Cochlear in Europe. It is a broad incumbent that competes for hearing-care clinician relationships in Benelux.

Emerging players

• Envoy Medical: Envoy Medical is an emerging player in active middle-ear and fully implanted hearing devices. It is a partial-overlap competitor addressing hearing loss with alternative implant architectures, intersecting with Cochlear's implantable-hearing category.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/CochlearEMEA
• Facebookfacebook.com/CochlearNederland
• LinkedInlinkedin.com/company/cochlear-benelux-nv
• Instagraminstagram.com/cochlearnederland

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cochlear Benelux NV